TROG Cancer Research
Members Login   CQMS Login

Subspecialty Working Parties

The primary role of the subspecialty working parties is to advise the TROG Scientific Committee (TSC) on current trials and projects in the subspecialty research portfolio, on any gaps in research activities, on new research concepts including the scientific merit of the proposal and on the research priorities to be adopted by TROG. Please see the Working Party Terms of Reference for more detailed information.

The Subspecialty Working Parties will represent radiation oncology, medical physics, radiation therapy, statistics, consumers and other appropriate disciplines (e.g. medical oncology, allied health).

If you are interested in joining a working party please complete an Expression of Interest form. 

Contact the TROG office on +61 2 40143911 |  if you would like further information on joining a Working Party. 

Breast Working Party

Chair: Boon Chua

Group contact:
Tamica Humby

TROG Central Office
Phone: +61 2 4014 3905

Genitourinary Working Party

Chair: David Pryor 

Group contact:
Oliva Cook
TROG Central Office
Phone: +61 2 4014 3918

Head, Neck and Skin Working Party

Chair: June Corry

Group contact:
Patrick Wheeler
TROG Central Office
Phone: +61 2 4014 3903

Lung Working Party

Chair: Fiona Hegi-Johnson

Group contact:
Annette Dempsey
TROG Central Office
Phone: +61 2 4014 3916

Neuro-Oncology Working Party

*In late 2019 the TROG membership expressed a need for a Neuro-oncology Working Party to be developed. If you are interested in joining this committee, please complete the Expression of Interest form.     

Chair: To be appointed 

Group contact:
TROG Central Office
Phone: +61 2 4014 3911

Become a TROG member and join our community of over 1,000 health professionals.

Latest News

  • 15 May 2020

    The diagnosis of ductal carcinoma in situ (DCIS) of the breast has increased substantially due to mammographic screening, and now accounts for 25 per cent of screen-detected breast cancer. Over 1,600 women are diagnosed with DCIS in Australia every year. However, unlike invasive breast cancer, there are limited knowledge and experience for patients and clinicians to draw on when this now common diagnosis of DCIS is made.

  • 15 Apr 2020

    Prostate cancer is one of the most common cancers amongst men, with one in six men diagnosed before their 85th birthday (Cancer Australia). In fact, in 2019 alone over 19,000 men in Australia were diagnosed with prostate cancer.

  • 06 Apr 2020

    p style="text-align: center;">_ src="/sitefiles/trogcomau/trog_team_2020.jpg" style="height: 333px; width: 500px;" />   covid-19 and the regulations around social distancing has affected an increasing number of events across australia, including the yearly gathering of radiation...

  • 01 Apr 2020

    The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we operate clinical trials – those that are underway, set t...

  • 15 Jan 2020

    _ src="/sitefiles/trogcomau/fbp_0378_large.jpg" /> new research by the university of new south wales (unsw), presented at the clinical oncology society of australia’s (cosa) annual scientific meeting (asm) found that increased use of radiation therapy for prostate cancer patients c...

  • 13 Sep 2019

    trog cancer research will work with clinicians at townsville hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new mri linac technology to benefit cancer patients. img src="/sitefiles/trogcomau/tro_trog_cancer_resear...

  • 09 Sep 2019

    TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.  The workshop facilitated by Ms Alison Evans, Hea...

  • 03 Sep 2019

    trog cancer research are proud to announce that we have two new additions to the trog cancer research board of directors. joining our team is professor annette haworth and denis byron. appointed as a non-radiation oncology director, annette is an accredited medical physicist wh...